SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950116-99-000246
Filing Date
1999-02-16
Accepted
1999-02-16 00:00:00
Documents
1
Group Members
HAROLD R. WERNERHEALTHCARE PARTNERS II, L.P.HEALTHCARE PARTNERS III, L.P.HEALTHCARE PARTNERS IV, L.P.HEALTHCARE PARTNERS V, L.P.HEALTHCARE VENTURES II LPHEALTHCARE VENTURES II, L.P.HEALTHCARE VENTURES III, L.P.HEALTHCARE VENTURES IV, L.P.HEALTHCARE VENTUR

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 57302
  Complete submission text file 0000950116-99-000246.txt   59741
Mailing Address TWIN TOWERS AT METRO PARK 379 THORNALL AVENUE EDISON NJ 08837
Business Address TWIN TOWERS AT METRO PARK 379 THORNALL AVENUE EDISON NJ 08837 9089064613
HEALTHCARE VENTURES II LP (Filed by) CIK: 0000859649 (see all company filings)

IRS No.: 223015728 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 0000

Mailing Address
Business Address FOSSE HOUSE E ANTON COURT ICKNIELD WAY ANDOVER HANTS SP10 5 X0 1264333455
SHIRE PHARMACEUTICALS GROUP PLC (Subject) CIK: 0000936402 (see all company filings)

IRS No.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-55755 | Film No.: 99541460
SIC: 2834 Pharmaceutical Preparations